Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Clearside Biomedical (CLSD) IPO Opens Up 14%
June 2, 2016 11:17 AM EDTToday's IPO for Clearside Biomedical, Inc. (Nasdaq: CLSD) opened for trading at $8 after pricing 7,200,000 shares of its common stock at a public offering price of $7.00 per share.
Cowen and Company and Stifel are serving as joint book-running managers for the offering. Needham &... More
